GenScript Biotech

GenScript Biotech Corporation
TypePublic
SEHK: 1548
IndustryLife sciences
Founded2002
FoundersFangliang Zhang, Ye Wang, Luquan Wang
Headquarters
Key peopleShao Weihui, CEO
Websitewww.genscript.com Edit this at Wikidata

GenScript Biotech, fully known as GenScript Biotech Corporation, usually referred to as simply GenScript, is a Chinese biotech company. It was co-founded in 2002 in New Jersey by Fangliang Zhang, Ye Wang, and Luquan Wang. Headquartered in Nanjing, the company mainly provides life science research application instruments and services. It was listed on the Hong Kong Stock Exchange in 2015. The current rotating CEO of the firm is Shao Weihui, who also served as the chief operating officer and Chinese Communist Party Committee Secretary for the company. The company's main subsidiaries include Legend Biotech, ProBio Technology, and Bestzyme.

Outside of the United States, GenScript has established presences in China, Singapore, Japan, the United Kingdom, and the Netherlands, among others. The company's operations are divided into four main segments, CDMO platform, life-science services and products platform, integrated cell therapy platform, and industrial synthetic products platform. In September 2021, the firm and its subsidiary Probio received series A funding from Hillhouse Capital.